NewAmsterdam Pharma (NAMS) Revenue (2023 - 2025)
Historic Revenue for NewAmsterdam Pharma (NAMS) over the last 3 years, with Q3 2025 value amounting to $348000.0.
- NewAmsterdam Pharma's Revenue fell 9880.46% to $348000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35.2 million, marking a year-over-year increase of 490.86%. This contributed to the annual value of $45.6 million for FY2024, which is 22337.12% up from last year.
- Per NewAmsterdam Pharma's latest filing, its Revenue stood at $348000.0 for Q3 2025, which was down 9880.46% from $19.1 million recorded in Q2 2025.
- In the past 5 years, NewAmsterdam Pharma's Revenue registered a high of $29.1 million during Q3 2024, and its lowest value of $348000.0 during Q3 2025.
- Over the past 3 years, NewAmsterdam Pharma's median Revenue value was $2.9 million (recorded in 2023), while the average stood at $7.5 million.
- Per our database at Business Quant, NewAmsterdam Pharma's Revenue surged by 149053.55% in 2024 and then crashed by 9880.46% in 2025.
- Over the past 3 years, NewAmsterdam Pharma's Revenue (Quarter) stood at $803000.0 in 2023, then soared by 1490.54% to $12.8 million in 2024, then plummeted by 97.28% to $348000.0 in 2025.
- Its last three reported values are $348000.0 in Q3 2025, $19.1 million for Q2 2025, and $3.0 million during Q1 2025.